News & Media
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
BillionToOne named the Diagnostics Company of the Year by BioTech Breakthrough Awards
BillionToOne named the Diagnostics Company of the Year by BioTech Breakthrough Awards
Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth
Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth
The Green Room Podcast from Obstetrics & Gynecology-Interview with Jennifer Hoskovec, MS, author of “Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.”
The Green Room Podcast from Obstetrics & Gynecology-Interview with Jennifer Hoskovec, MS, author of “Cell-Free DNA Analysis for the Determination of Fetal Red Blood Cell Antigen Genotype in Individuals With Alloimmunized Pregnancies.”
A Major Addition to Austin’s Life Science Ecosystem with the Expansion of BillionToOne
A Major Addition to Austin’s Life Science Ecosystem with the Expansion of BillionToOne
Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital
Category Defining Molecular Diagnostics Company BillionToOne Further Solidifies its Long-Term Position by Securing $140 Million Non-Dilutive Financing with Oberland Capital
BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping
BillionToOne Announces Green Journal Publication that Underscores the Role of cell-free DNA NIPT for Fetal Red Blood Cell Antigen Genotyping
Social Posts